Incidence, risk factors, and outcome of contrast-induced nephropathy following contrast enhanced computed tomography: A pragmatic, observational study

Abstract

Background: Despite significant advancement in molecular properties, intravascular 
injection of iodinated contrast agents (CAs) is associated with the risk of contrast induced 
nephropathy (CIN). Additionally, the incidence, risk factors, and outcome of CIN is variable 
across the literature. Thus, the study assessed the incidence, risk factors, and outcome of CIN 
following contrast enhanced computed tomography (CECT).